The Peptide Cancer Vaccine Market is expected to reach with a Compound Annual Growth Rate (CAGR) of 11% during the forecast period 2022-2028. Peptide cancer vaccines help induce and expand tumor-specific T cells that can control or eradicate tumors. A vaccine is a tumor antigen bound to a vaccine adjuvant and consists of one or […]